Tolerability and safety of rituximab (MabThera®)
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference143 articles.
1. The mechanisms of action of rituximab in the elimination of tumor cells;Johnson;Semin Oncol,2003
2. Roche Global Drug Safety database. Data on file, 2004.
3. Treatment of monomorphic B-cell lymphoma with rituximab after liver transplantation in a child;Bueno;Pediatr Transplant,2003
4. Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimaeric anti-CD20 monoclonal antibody and autologous stem cell transplantation;Corbacioglu;J Pediatr Hematol Oncol,2003
5. Anti-CD20 monoclonal antibody (rituximab) for therapy of mediastinal CD20-positive large B-cell non-Hodgkin lymphoma with a local tumor extension into the lung of a 10-year-old girl;Culic;J Pediatr Hematol Oncol,2003
Cited by 421 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohort;Clinical Rheumatology;2024-08-28
2. Sudden unexpected death after initial infusion of rituximab for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma: an autopsy case;Diagnostic Pathology;2024-06-28
3. Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives;Clinical Microbiology Reviews;2024-06-13
4. Thrombotic Thrombocytopenic Purpura in the Setting of Cirrhosis and Baseline Thrombocytopenia;Cureus;2024-05-07
5. Latent tuberculosis diagnostics: current scenario and review;Monaldi Archives for Chest Disease;2024-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3